← All organizations

Beijing Pearl Biotechnology Limited Liability Company

Government

Also known as: BEIJING | Beijing Pearl Biotechnology Limited Liability Company

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jun 30, 2026

Timeline

2020s

Apr 26, 2021
fluvastatin— Marketing Organization

Drugs by trial phase (8 distinct, 7 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

plb1003

Indications

Studied for

Marketed drugs (3)

Recent trials (7)

NCT07285148Lead sponsorPhase 1/Phase 2Jun 30, 2026
NCT05989542Lead sponsorPhase 3Jun 29, 2023
NCT04258033Lead sponsorPhase 2Jan 17, 2020
NCT06105619Lead sponsorPhase 2/Phase 3Oct 8, 2018
NCT03130881Lead sponsorPhase 1Nov 8, 2016
NCT02978261Lead sponsorPhase 1Sep 1, 2016
NCT02896231Lead sponsorPhase 1Apr 1, 2016

Details

Last known activity: Jun 30, 2026